B cell homeostasis Cytokines Antisynthetase Anémie hémolytique Aged Lysosomal storage diseases Biomarker Autoimmune diseases Cancer Antibodies Adeno-associated vector Adeno-associated virus vector Anti-drug antibodies Anti-agalsidase antibodies Prognosis Machine learning Case reports Systems biology Autoantibody DM Antisynthétase Muscle Auto‐antibodies Analyses multidimensionnelles Idiopathic inflammatory myopathies Anti-MDA5 autoantibodies AAV antibody Pharmacology Immune checkpoint inhibitors Acid-alpha-glucosidase Data integration Myocarditis Anti-interleukin-6 Inborn errors of metabolism Biomarqueurs Biopsy Auto-immunité Cardio-oncology Middle Aged Biomarkers Adjudication AAV vector Antibody responses Anti-IgE IgG Active Assisted communication devices Myositis and muscle disease Antisynthetase syndrome Inflammatory myopathy AAV Fabry disease Dermatomyositis Auto-antibodies Sphingosine-1-phosphate Dependovirus/genetics/immunology Aldostérone Deep immune profiling Bioelectrical impedance analysis Antiphospholipid syndrome Autoantibodies COVID-19 Myopathy Aldosterone Anticorps spécifique des myosites Adverse drug reactions Polymyositis Adolescence Immunotherapy Arthritis Inflammation Agalsidase Mass cytometry Gene therapy Humans Adult Animals Multidisciplinarity Skeletal muscle AAV vectors Outcome measures Amyotrophic lateral sclerosis Abnormal movement Interferon B-lymphocyte AAV humoral immunity Anti-Mi2 Autoimmunity Inclusion body myositis Male Anti-synthetase syndrome Female Anti‐mitochondrial antibodies IMNM Interstitial lung disease IBM Amyotrophy Adeno-associated virus Acute Kidney Injury/epidemiology/etiology Myositis Anticorps anti-agalsidase